A peptide construct containing B-cell and T-cell epitopes from the foot- and-mouth disease viral VP1 protein induces efficient antiviral protection

Vaccine

Volumn 17, Issue 6, 1999, Pages 577-584

  Volpina, O M ^a   Surovoy, A Yu ^a   Zhmak, M N ^a   Kuprianova, M A ^a   Koroev, D O ^a   Chepurkin, A V ^b   Toloknov, A S ^b   Ivanov, V T ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b Federal Centre for Animal Health (FGI ARRIAH)   (Russian Federation)

Author keywords

B , T epitopes; Foot and mouth disease; Peptides

Indexed keywords

EPITOPE; FOOT AND MOUTH DISEASE VACCINE; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; B LYMPHOCYTE; CATTLE; FEMALE; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GUINEA PIG; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SHEEP; T LYMPHOCYTE; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; APHTHOVIRUS; CAPSID; CAPSID PROTEINS; CATTLE; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FEMALE; GUINEA PIGS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RABBITS; SHEEP; T-LYMPHOCYTES; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0033547998     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00236-9     Document Type: Article

References (12)

1. 22 virus strain. Vaccine. 14:1996;1375-1380.
2. Taboga O., Tami C., Carrillo E.et al. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutant. J Virol. 71:1997;2606-2614.
3. Francis M.J., Hastings G.Z., Syred A.D., McGinn B., Brown F., Rowlands D.J. Nonresponsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature. 330:1987;168-170.
4. Levely M.E., Mitchell M.A., Nicholas J.A. Synthetic immunogens constructed from T-cell and B-cell stimulating peptides (T:B chimeras): preferential stimulation of unique T- and B-cell specificities is influenced by immunogen configuration. Cell Immunol. 125:1990;65-78.
5. 1 protein. FEBS Lett. 333:1993;175-178.
6. Yarov A.V., Gelfanov V.M., Grechaninova L.A.et al. Antigenic structure of foot-and-mouth disease virus. V. Protection of susceptible animals with the use of a synthetic peptide. Bioorg Khim. 15:1989;1313-1317. (in Russian).
7. 22 strains of foot-and-mouth disease virus. Bioorg Khim. 15:1989;1185-1192. (in Russian).
8. 22 strains. Bioorg Khim. 17:1991;596-605. (in Russian).
9. 1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J Immunol. 146:1991;749-755.
10. 1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. J Virol. 69:1995;4511-4514.
11. Rouaix F., Gras-Masse H., Mazingue C.et al. Effect of a lipopeptidic formulation on macrophage activation and peptide presentation to T-cells. Vaccine. 12:1994;1209-1214.
12. Doel T.R., Gale C., Do Amaral C.M.C.F., Mulcahy G., DiMarchi R. Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease. J Virol. 64:1990;2260-2264.